Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.

Drini, Musa

Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease. [electronic resource] - The Medical journal of Australia Oct 2008 - 464-5 p. digital

Publication Type: Case Reports; Journal Article

0025-729X

10.5694/j.1326-5377.2008.tb02124.x doi


Adult
Antibodies, Monoclonal--adverse effects
Crohn Disease--drug therapy
Fatal Outcome
Humans
Immunologic Factors--adverse effects
Infliximab
Liver Neoplasms--chemically induced
Lymphoma, T-Cell--chemically induced
Male
Splenic Neoplasms--chemically induced
Tumor Necrosis Factor-alpha--antagonists & inhibitors